CIP
HARP

Chartwell Investment Partners’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Chartwell Investment Partners’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,716
Closed -$568K – 441
2021
Q1 		$568K Sell
2,716
-146
-5% -$29.3K 0.02% 392
2020
Q4 		$475K Buy
+2,862
New +$442K 0.02% 406

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Chartwell Investment Partners's HARP Position: Q2 2021 in Review

Chartwell Investment Partners sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2021, closing a stake of 2,716 shares — an estimated $568K sold.

Chartwell Investment Partners first reported a position in HARP in Q4 2020 and held it in 2 quarters. The position peaked at $568K in Q1 2021. 85 funds tracked by Wall St. Rank hold HARP as of Q2 2021.

  • Chartwell Investment Partners reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Chartwell Investment Partners sold 2,716 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $568K.
  • Chartwell Investment Partners first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Chartwell Investment Partners's Harpoon Therapeutics, Inc. Common Stock position peaked at $568K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Chartwell Investment Partners's 13F filing for Q2 2021, filed 19 Jul 2021.